Compugen Ltd.

1.80-0.1400-7.22%Vol 785.31K1Y Perf -77.70%
Jun 28th, 2022 16:00 DELAYED
BID1.78 ASK2.25
Open1.94 Previous Close1.94
Pre-Market- After-Market1.80
 - -  - -%
Target Price
12.17 
Analyst Rating
Strong Buy 1.00
Potential %
576.11 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     47.28
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
     39.20
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
3.33 
Earnings Rating
Strong Buy
Market Cap155.58M 
Earnings Date
27th Jul 2022
Alpha-0.02 Standard Deviation0.23
Beta2.43 

Today's Price Range

1.781.95

52W Range

1.559.20

5 Year PE Ratio Range

-13.10-6.90

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
6.59%
1 Month
3.74%
3 Months
-39.75%
6 Months
-53.03%
1 Year
-77.70%
3 Years
-49.48%
5 Years
-50.89%
10 Years
-48.54%

TickerPriceChg.Chg.%
CGEN1.80-0.1400-7.22
AAPL137.44-4.2200-2.98
GOOG2 251.43-81.0200-3.47
MSFT256.48-8.4100-3.17
XOM91.502.47002.77
WFC40.18-0.0600-0.15
JNJ176.94-5.1800-2.84
FB196.640.99000.51
GE65.88-0.8300-1.24
JPM115.82-0.5600-0.48
Financial StrengthValueIndustryS&P 500US Markets
0.30
7.10
0.02
0.03
-
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
89.00
-580.10
-580.10
-
-
RevenueValueIndustryS&P 500US Markets
6.00M
0.07
-78.92
-11.11
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.12-0.118.33
Q04 2021-0.15-0.1033.33
Q03 2021-0.13-0.0746.15
Q02 2021-0.12-0.118.33
Q01 2021-0.12-0.120.00
Q04 2020-0.10-0.100.00
Q03 2020-0.09-0.090.00
Q02 2020-0.10-0.0820.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.127.69Positive
9/2022 QR-0.137.14Positive
12/2022 FY-0.495.77Positive
12/2023 FY-0.583.33Positive
Next Report Date27th Jul 2022
Estimated EPS Next Report-0.12
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume785.31K
Shares Outstanding86.43K
Shares Float66.76M
Trades Count6.12K
Dollar Volume1.45M
Avg. Volume786.34K
Avg. Weekly Volume638.24K
Avg. Monthly Volume829.73K
Avg. Quarterly Volume891.06K

Compugen Ltd. (NASDAQ: CGEN) stock closed at 1.94 per share at the end of the most recent trading day (a -7.18% change compared to the prior day closing price) with a volume of 539.67K shares and market capitalization of 155.58M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 68 people. Compugen Ltd. CEO is Anat Cohen-Dayag.

The one-year performance of Compugen Ltd. stock is -77.7%, while year-to-date (YTD) performance is -54.88%. CGEN stock has a five-year performance of -50.89%. Its 52-week range is between 1.545 and 9.2, which gives CGEN stock a 52-week price range ratio of 3.33%

Compugen Ltd. currently has a PE ratio of -4.60, a price-to-book (PB) ratio of 1.60, a price-to-sale (PS) ratio of 27.95, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -27.91%, a ROC of -32.47% and a ROE of -33.53%. The company’s profit margin is -%, its EBITDA margin is -580.10%, and its revenue ttm is $6.00 Million , which makes it $0.07 revenue per share.

Of the last four earnings reports from Compugen Ltd., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.12 for the next earnings report. Compugen Ltd.’s next earnings report date is 27th Jul 2022.

The consensus rating of Wall Street analysts for Compugen Ltd. is Strong Buy (1), with a target price of $12.17, which is +576.11% compared to the current price. The earnings rating for Compugen Ltd. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Compugen Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Compugen Ltd. has a Neutral technical analysis rating based on Technical Indicators (ADX : 22.74, ATR14 : 0.16, CCI20 : 108.20, Chaikin Money Flow : -0.02, MACD : -0.02, Money Flow Index : 61.40, ROC : 3.74, RSI : 51.72, STOCH (14,3) : 63.20, STOCH RSI : 0.59, UO : 57.97, Williams %R : -36.80), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Compugen Ltd. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (100.00 %)
6 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Compugen Ltd.

Compugen Ltd is a therapeutic discovery company. It is involved in the business of using its predictive discovery infrastructure to identify novel drug targets and develop biologics. The firm's therapeutic pipeline mainly consists of early-stage immuno-oncology programs aimed at harnessing the immune system to fight cancer. It focuses on immune checkpoint target candidates which are predicted to serve drug targets for cancer immunotherapies addressing various cancer types and also autoimmune diseases.

CEO: Anat Cohen-Dayag

Telephone: +972 37658585

Address: 26 Harokmim Street, Holon 5885849, , IL

Number of employees: 68

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

53%47%

Bearish Bullish

60%40%

TipRanks News for CGEN

News

Stocktwits